Dr Jade Scott-Blagrove was the youngest governor for the University Hospitals Bristol NHS FT aged 17 and worked as a healthcare assistant at Frenchay Hospital in neurosurgery theatres prior to entering medical school. Jade studied medicine and intercalated in neuroscience at the University of Manchester and has been a radiology registrar in Cambridge since 2020. Jade is the founder and current chair of Widening Participation Medics Network (WPMN) which serves to support & advocate for aspiring & current medical students and doctors from underrepresented groups. She is also a member of the National Medical Schools Widening Participation Forum Junior Doctors Committee. Jade co-founded RadReach after recognising that barriers remain in place for those from widening participation backgrounds when applying to our specialties and beyond.
Meet the RadReach founders, patrons & ambassadors
LEARN MORERadReach Founders
Dr Anu Obaro is a consultant radiologist and PhD researcher studying bowel cancer imaging interpretation at St Mark’s Hospital, London. She is the recipient of the John Nichols Prize for Research 2020 and was awarded Diversity Champion - COVID Heart Hero Award 2021 for her COVID vaccine advocacy work. Anu is co-chair of the Independent Staff Insight Group which ensures an inclusive approach to developing Trust-wide strategies at London North West Healthcare Trust. She is a passionate educator and racial equity advocate having presented talks on racism which have been viewed all over the world. As co-founder of RadReach she has a desire to increase the number of people from under-represented groups in radiology while also ensuring that they have an enriching and supportive training experience.
Hannah Tharmalingam trained in medicine at the University of Oxford graduating in 2009 with a First-Class Honours degree. She trained in clinical oncology in North London within which she completed an MD (Res) degree evaluating advanced radiotherapy techniques in high-risk prostate cancer. She was appointed a consultant in clinical oncology at Mount Vernon Cancer Centre in 2019 where she specialises in gynaecological and urological malignancies with an interest in HDR brachytherapy.
She has a strong interest in medical education and was awarded an Associate Fellowship of the Higher Education Academy as a trainee. At the RCR, since 2017, she has been a Clinical Fellow in education leading on the re-write of the curriculum and the new joint training pathway model with medical oncology as well as an associate member of the FRCR Part 2A Examination Board. During this time, she was also Vice-Chair of the Oncology Registrars’ Forum representing trainees on various RCR boards and committees.
Her other interests include radiotherapy advocacy, global health and Arsenal F.C. She spends far too much of her spare time worrying about her Fantasy Football team.
Dr Jade Scott-Blagrove was the youngest governor for the University Hospitals Bristol NHS FT aged 17 and worked as a healthcare assistant at Frenchay Hospital in neurosurgery theatres prior to entering medical school. Jade studied medicine and intercalated in neuroscience at the University of Manchester and has been a radiology registrar in Cambridge since 2020. Jade is the founder and current chair of Widening Participation Medics Network (WPMN) which serves to support & advocate for aspiring & current medical students and doctors from underrepresented groups. She is also a member of the National Medical Schools Widening Participation Forum Junior Doctors Committee. Jade co-founded RadReach after recognising that barriers remain in place for those from widening participation backgrounds when applying to our specialties and beyond.
Dr Anu Obaro is a consultant radiologist and PhD researcher studying bowel cancer imaging interpretation at St Mark’s Hospital, London. She is the recipient of the John Nichols Prize for Research 2020 and was awarded Diversity Champion - COVID Heart Hero Award 2021 for her COVID vaccine advocacy work. Anu is co-chair of the Independent Staff Insight Group which ensures an inclusive approach to developing Trust-wide strategies at London North West Healthcare Trust. She is a passionate educator and racial equity advocate having presented talks on racism which have been viewed all over the world. As co-founder of RadReach she has a desire to increase the number of people from under-represented groups in radiology while also ensuring that they have an enriching and supportive training experience.
Hannah Tharmalingam trained in medicine at the University of Oxford graduating in 2009 with a First-Class Honours degree. She trained in clinical oncology in North London within which she completed an MD (Res) degree evaluating advanced radiotherapy techniques in high-risk prostate cancer. She was appointed a consultant in clinical oncology at Mount Vernon Cancer Centre in 2019 where she specialises in gynaecological and urological malignancies with an interest in HDR brachytherapy.
She has a strong interest in medical education and was awarded an Associate Fellowship of the Higher Education Academy as a trainee. At the RCR, since 2017, she has been a Clinical Fellow in education leading on the re-write of the curriculum and the new joint training pathway model with medical oncology as well as an associate member of the FRCR Part 2A Examination Board. During this time, she was also Vice-Chair of the Oncology Registrars’ Forum representing trainees on various RCR boards and committees.
Her other interests include radiotherapy advocacy, global health and Arsenal F.C. She spends far too much of her spare time worrying about her Fantasy Football team.
RadReach Patrons
Dr McGinty did her medical training in Ireland at the National University and then came to the USA for residency at the University of Pittsburgh where she was Chief Resident. Her fellowship was in Women's Imaging at the Massachusetts General Hospital. While working at Montefiore Medical Centre in the Bronx she completed an MBA at Columbia University.
She is an internationally recognized expert in imaging economics. She has served an advisor to the CPT Editorial Panel, the JCAHO and the National Quality Forum. She was Chair of the American College of Radiology's Commission on Economics and was the radiology member of the AMA’s Relative Value Update Committee from 2012-2016.
In May 2018 she was elected as the Chair of the ACR's Board of Chancellors, the first woman to hold this office. She was until 2013 Managing Partner of a 70-physician multispecialty medical group on Long Island. In 2014 she joined the faculty at Weill Cornell Medicine in New York City. As well as her clinical practice there she serves as Chief Strategy Officer and Chief Contracting Officer for the Weill Cornell Physician Organization’s more than 1600 members. Her role as lead negotiator for managed care contracts at Weill Cornell Medicine incorporates both traditional fee for service agreements as well as value-based payment arrangements. In September 2021 she was appointed as Senior Associate Dean for Clinical Affairs.
She is a member of the board of NextGen Healthcare (NXGN) and from 2014-2021 served as a Non-Executive Director of IDA Ireland, the national foreign direct investment agency.
Her published work has focused on payment models for imaging, most recently a bundled payment for breast cancer screening. Recently she has focused on the impact of Artificial Intelligence on Medical Imaging and has spoken at the Turing Institute and to the WHO Focus Group on AI in Healthcare on this topic. In 2015 she was voted Radiology’s Most Effective Educator by the readers of Aunt Minnie, a radiology news site with more than 140,000 members. She has more than 15000 followers on Twitter.
Amaka C Offiah is Professor in Paediatric Musculoskeletal Imaging and consultant paediatric radiologist at the University of Sheffield and Sheffield Children’s NHS Foundation Trust, Sheffield, UK. She is probably the first black African female professor at the University of Sheffield and probably only the second black African female professor in medicine in the UK.
Graduating as a doctor from Ahmadu Bello University, Zaria, Nigeria, Professor Offiah obtained a PhD while at Great Ormond Street Hospital for Children and the Institute of Child Health, UCL, London. She has published approximately 200 peer reviewed articles, book chapters and books and given over 250 invited national and international lectures. She has been involved in the development of national guidelines related to investigating suspected physical abuse in children and has published a textbook on the subject.
Professor Offiah is the first BAME and first female Managing Editor of the journal Peadiatric Radiology, Convener of the Skeletal Dysplasia Group for Teaching and Research and Chairperson of the European Society of Paediatric Radiology Child Abuse Taskforce. She was recently appointed co-Chair for the North East Region of the Experts in the Family Justice System Committee. Professor Offiah is Director for Equality, Diversity & Inclusion for the Department of Oncology & Metabolism at the University of Sheffield, Chair of the Scientific Advisory Committee at Sheffield Children’s Hospital and Chair of the University of Sheffield BAME Staff Network.
Passionate about children’s welfare and Equality, Diversity and Inclusion, Professor Offiah is a Trustee for Sheffield Children’s Hospital and a Governor for Notre Dame High School, Sheffield.
Professor Offiah is married and has two children and a cat.
Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She joined The Christie in 2008 specialising in urology and sarcoma and has a strong interest in translational research. In 2013, she decided to focus on radiotherapy-related research in prostate and bladder cancers. Her current research aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side-effects, and predictive biomarkers to determine which patients benefit from different treatments. Within the Division of Cancer Sciences, The University of Manchester, she is clinical lead for advanced radiotherapy, including the MRLinac project, and is co-Group Leader of The Translational Radiobiology Group.
Professor Choudhury graduated from Trinity College, Cambridge, but undertook her Clinical Oncology training at the Yorkshire Deanery from 2000-2008. Between 2005 and 2007, she was a Cancer Research UK Clinical Training Research Fellow and she undertook her PhD at the University of Leeds and Princess Margaret Hospital in Toronto, Canada. She has a lead role in education and training for specialist registrars and clinical fellows.
Over the past few years, Professor Choudhury has been involved with national concerns such as the Royal College of Radiologists, the National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Research Working Group (CTRad), the NCRI Bladder Clinical Studies Group and the National Institute of Health and Care Excellence (NICE). Professor Choudhury was Senior Editor for genito-urinary cancers for the International Journal of Radiation Oncology • Biology • Physics (The Red Journal). Since early 2021, she has been the Editor in Chief of Clinical Oncology.
Professor Hoskin trained in clinical oncology at the Royal Marsden Hospital London and has been a consultant in clinical oncology at Mount Vernon Cancer Centre, Northwood since 1992. Professor in Clinical Oncology in the University of Manchester and Honorary consultant in clinical oncology at the Christie Hospital, Manchester. Research interests focus on radiosensitisation, biomarkers, radiotherapy quality assurance, palliative radiotherapy, and brachytherapy.
Dr McGinty did her medical training in Ireland at the National University and then came to the USA for residency at the University of Pittsburgh where she was Chief Resident. Her fellowship was in Women's Imaging at the Massachusetts General Hospital. While working at Montefiore Medical Centre in the Bronx she completed an MBA at Columbia University.
She is an internationally recognized expert in imaging economics. She has served an advisor to the CPT Editorial Panel, the JCAHO and the National Quality Forum. She was Chair of the American College of Radiology's Commission on Economics and was the radiology member of the AMA’s Relative Value Update Committee from 2012-2016.
In May 2018 she was elected as the Chair of the ACR's Board of Chancellors, the first woman to hold this office. She was until 2013 Managing Partner of a 70-physician multispecialty medical group on Long Island. In 2014 she joined the faculty at Weill Cornell Medicine in New York City. As well as her clinical practice there she serves as Chief Strategy Officer and Chief Contracting Officer for the Weill Cornell Physician Organization’s more than 1600 members. Her role as lead negotiator for managed care contracts at Weill Cornell Medicine incorporates both traditional fee for service agreements as well as value-based payment arrangements. In September 2021 she was appointed as Senior Associate Dean for Clinical Affairs.
She is a member of the board of NextGen Healthcare (NXGN) and from 2014-2021 served as a Non-Executive Director of IDA Ireland, the national foreign direct investment agency.
Her published work has focused on payment models for imaging, most recently a bundled payment for breast cancer screening. Recently she has focused on the impact of Artificial Intelligence on Medical Imaging and has spoken at the Turing Institute and to the WHO Focus Group on AI in Healthcare on this topic. In 2015 she was voted Radiology’s Most Effective Educator by the readers of Aunt Minnie, a radiology news site with more than 140,000 members. She has more than 15000 followers on Twitter.
Amaka C Offiah is Professor in Paediatric Musculoskeletal Imaging and consultant paediatric radiologist at the University of Sheffield and Sheffield Children’s NHS Foundation Trust, Sheffield, UK. She is probably the first black African female professor at the University of Sheffield and probably only the second black African female professor in medicine in the UK.
Graduating as a doctor from Ahmadu Bello University, Zaria, Nigeria, Professor Offiah obtained a PhD while at Great Ormond Street Hospital for Children and the Institute of Child Health, UCL, London. She has published approximately 200 peer reviewed articles, book chapters and books and given over 250 invited national and international lectures. She has been involved in the development of national guidelines related to investigating suspected physical abuse in children and has published a textbook on the subject.
Professor Offiah is the first BAME and first female Managing Editor of the journal Peadiatric Radiology, Convener of the Skeletal Dysplasia Group for Teaching and Research and Chairperson of the European Society of Paediatric Radiology Child Abuse Taskforce. She was recently appointed co-Chair for the North East Region of the Experts in the Family Justice System Committee. Professor Offiah is Director for Equality, Diversity & Inclusion for the Department of Oncology & Metabolism at the University of Sheffield, Chair of the Scientific Advisory Committee at Sheffield Children’s Hospital and Chair of the University of Sheffield BAME Staff Network.
Passionate about children’s welfare and Equality, Diversity and Inclusion, Professor Offiah is a Trustee for Sheffield Children’s Hospital and a Governor for Notre Dame High School, Sheffield.
Professor Offiah is married and has two children and a cat.
Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She joined The Christie in 2008 specialising in urology and sarcoma and has a strong interest in translational research. In 2013, she decided to focus on radiotherapy-related research in prostate and bladder cancers. Her current research aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side-effects, and predictive biomarkers to determine which patients benefit from different treatments. Within the Division of Cancer Sciences, The University of Manchester, she is clinical lead for advanced radiotherapy, including the MRLinac project, and is co-Group Leader of The Translational Radiobiology Group.
Professor Choudhury graduated from Trinity College, Cambridge, but undertook her Clinical Oncology training at the Yorkshire Deanery from 2000-2008. Between 2005 and 2007, she was a Cancer Research UK Clinical Training Research Fellow and she undertook her PhD at the University of Leeds and Princess Margaret Hospital in Toronto, Canada. She has a lead role in education and training for specialist registrars and clinical fellows.
Over the past few years, Professor Choudhury has been involved with national concerns such as the Royal College of Radiologists, the National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Research Working Group (CTRad), the NCRI Bladder Clinical Studies Group and the National Institute of Health and Care Excellence (NICE). Professor Choudhury was Senior Editor for genito-urinary cancers for the International Journal of Radiation Oncology • Biology • Physics (The Red Journal). Since early 2021, she has been the Editor in Chief of Clinical Oncology.
Professor Hoskin trained in clinical oncology at the Royal Marsden Hospital London and has been a consultant in clinical oncology at Mount Vernon Cancer Centre, Northwood since 1992. Professor in Clinical Oncology in the University of Manchester and Honorary consultant in clinical oncology at the Christie Hospital, Manchester. Research interests focus on radiosensitisation, biomarkers, radiotherapy quality assurance, palliative radiotherapy, and brachytherapy.
RadReach Ambassadors
Nicky Thorp trained in medicine at the University of Leicester, graduating in 1990. She completed her specialist oncology training at the Clatterbridge Cancer Centre. She was appointed as a consultant clinical oncologist in 2001 at Clatterbridge with subspecialty interests in breast cancer, paediatric radiotherapy and late effects. In 2019 she took up her post at the Christie Hospital in Manchester specialising in photon and proton beam therapy for children. Her research interests are in paediatric tumours and radiotherapy quality assurance. She was previously radiotherapy lead for the NCRI CCL CNS Subgroup and is UK radiotherapy lead for the pan-European SIOP Ependymoma II study.
Nicky was Medical Director for Professional Practice for Clinical Oncology at the Royal College of Radiologists from September 2021 to August 2024 and and is currently Co-lead for Wellbeing at the RCR. She previously served two terms on the RCR CO Faculty Board.
Nicky was Associate Medical Director at Clatterbridge between 2010 and 2016. Her roles included clinical lead for the new build Clatterbridge Cancer Centre-Liverpool.
She served two terms on the Children’s Cancer and Leukaemia Group (CCLG) Executive and is past chair of the CCLG Radiotherapy and Neuro-oncology Groups.
Dr Priya Suresh completed her undergraduate training in India, followed by her MRCP in Manchester. Her radiology training was in Manchester and Plymouth, followed by a Fellowship at the Royal National Orthopaedic Hospital in Stanmore.
Her work with RCR started in 2011 when she initiated READ and served as the Programme Director. Dr Suresh has also sat on several RCR committees including the Curriculum Committee, Specialty Training Board and Faculty Board. She has chaired the FRCR 2A MSK SBA and is currently the Lead for the MSK module of RITI and SIG Lead for the iRefer MSK guidelines.
She is the Academy Lead for the Peninsula Radiology Academy, Training Programme Director and Teaching Lead for imaging and Honorary University fellow.
Dr Suresh's tenure as Medical Director, Education and Training, Clinical Radiology at the RCR is 2022-2025.
Nicky Thorp trained in medicine at the University of Leicester, graduating in 1990. She completed her specialist oncology training at the Clatterbridge Cancer Centre. She was appointed as a consultant clinical oncologist in 2001 at Clatterbridge with subspecialty interests in breast cancer, paediatric radiotherapy and late effects. In 2019 she took up her post at the Christie Hospital in Manchester specialising in photon and proton beam therapy for children. Her research interests are in paediatric tumours and radiotherapy quality assurance. She was previously radiotherapy lead for the NCRI CCL CNS Subgroup and is UK radiotherapy lead for the pan-European SIOP Ependymoma II study.
Nicky was Medical Director for Professional Practice for Clinical Oncology at the Royal College of Radiologists from September 2021 to August 2024 and and is currently Co-lead for Wellbeing at the RCR. She previously served two terms on the RCR CO Faculty Board.
Nicky was Associate Medical Director at Clatterbridge between 2010 and 2016. Her roles included clinical lead for the new build Clatterbridge Cancer Centre-Liverpool.
She served two terms on the Children’s Cancer and Leukaemia Group (CCLG) Executive and is past chair of the CCLG Radiotherapy and Neuro-oncology Groups.
Dr Priya Suresh completed her undergraduate training in India, followed by her MRCP in Manchester. Her radiology training was in Manchester and Plymouth, followed by a Fellowship at the Royal National Orthopaedic Hospital in Stanmore.
Her work with RCR started in 2011 when she initiated READ and served as the Programme Director. Dr Suresh has also sat on several RCR committees including the Curriculum Committee, Specialty Training Board and Faculty Board. She has chaired the FRCR 2A MSK SBA and is currently the Lead for the MSK module of RITI and SIG Lead for the iRefer MSK guidelines.
She is the Academy Lead for the Peninsula Radiology Academy, Training Programme Director and Teaching Lead for imaging and Honorary University fellow.
Dr Suresh's tenure as Medical Director, Education and Training, Clinical Radiology at the RCR is 2022-2025.
Find out more about CPD and events
Discover all the events and CPD opportunities offered by the college.
